Translink is a project that will have a duration of four years and a budget of 7.8 M \u20ac , co-financed by the European Union under the 7th Framework Programme.<\/p>\n
Dr. Rafael M\u00e1\u00f1ez , director of the project in 2 hospitals of the ICS (Catalan Health Institute , stresses that this project will apply the knowledge generated in medical practice , with real potential to impact on improving the process of biological cardiac prostheses.<\/p>\n
Each year 300,000 patients benefit from a biological heart valve prosthesis with animal tissues , which have advantages over mechanical prostheses . The replacement of these valves is the second most common surgical procedure in cardiac surgery , so that the results of this public-private partnership will have a major impact on the population.<\/p>\n
Kick-off of Translink<\/strong><\/p>\n On 23 and 24 September , Padua (Italy ) has just welcomed the launch meeting (kick -off ) of the European project ” TRANSLINK ” ( acronym for ‘ ” Defining the role of xeno -directed and autoimmune events in patients Receiving Animal -derived bioprosthetic heart valves “), which aims to determine the factors that govern the risks of failure of heart valve prostheses of biological origin , and improve the life of them. The results of this project will have a significant impact on the population , as the conditions Associated With The heart valves are the third leading cause of cardiovascular disease and replacement of these prostheses is the second Most common surgical procedure in cardiac surgery.<\/p>\n ” TRANSLINK ” will be developed through an international consortium composed of 13 members (6 public research organizations, 4 hospitals and 3 SMEs ) in 6 European countries. Coordinated by the Azienda Ospedaliera di Padova (Italy ) – with complementary resources and capabilities that combines applied research in the clinical setting with medicinal chemistry , artificial intelligence, and biotechnology cell experimentation. The Spanish partners of the project are the Institut Catal\u00e0 de la Salut, the Bellvitge Institute for Biomedical Research ( IDIBELL ) , InKemia IUCT Group ( through its subsidiary IUCT, SA ) and the start -up Mind the Byte, based at the PCB . The consortium also involved the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale ( France ) , the Centre Hospitalier Universitaire de Nantes ( France ) , the University College of London ( United Kingdom) , the University of Tel Aviv (Israel ) , the University of Gothenburg ( Sweden) , the Regents of the University of California ( USA) and the Italian biotech Avantea.<\/p>\n","protected":false},"excerpt":{"rendered":" Translink is a project that will have a duration of four years and a budget of 7.8 M \u20ac , co-financed by the European Union under the 7th Framework Programme. Dr. Rafael M\u00e1\u00f1ez , director of the project in 2 hospitals of the ICS (Catalan Health Institute , stresses that this project will apply the […]<\/p>\n","protected":false},"author":6,"featured_media":19023,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[263,184,300],"tags":[],"class_list":["post-6282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infectious-disease-and-transplantation-program","category-innate-immunity-and-pathology-of-the-critical-patient","category-translational-medicine-area"],"publishpress_future_action":{"enabled":false,"date":"2025-03-02 05:09:53","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/6282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=6282"}],"version-history":[{"count":5,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/6282\/revisions"}],"predecessor-version":[{"id":19031,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/6282\/revisions\/19031"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media\/19023"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=6282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/categories?post=6282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/tags?post=6282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}